Global health benefits of mitigating ozone pollution with methane emission controls by West, J. Jason et al.
Global health benefits of mitigating ozone pollution
with methane emission controls
J. Jason West*†‡, Arlene M. Fiore§, Larry W. Horowitz§, and Denise L. Mauzerall*†¶
*Department of Geosciences and Atmospheric and Oceanic Sciences Program, Princeton University, Sayre Hall, Princeton, NJ 08544; †Woodrow Wilson
School of Public and International Affairs, Princeton University, Robertson Hall, Princeton, NJ 08544; and §Geophysical Fluid Dynamics Laboratory,
National Oceanic and Atmospheric Administration, 201 Forrestal Road, Princeton, NJ 08542
Communicated by James E. Hansen, Goddard Institute for Space Studies, New York, NY, January 11, 2006 (received for review September 6, 2005)
Methane (CH4) contributes to the growing global background
concentration of tropospheric ozone (O3), an air pollutant associ-
ated with premature mortality. Methane and ozone are also
important greenhouse gases. Reducing methane emissions there-
fore decreases surface ozone everywhere while slowing climate
warming, but although methane mitigation has been considered to
address climate change, it has not for air quality. Here we show
that global decreases in surface ozone concentrations, due to
methane mitigation, result in substantial and widespread de-
creases in premature human mortality. Reducing global anthropo-
genic methane emissions by 20% beginning in 2010 would de-
crease the average daily maximum 8-h surface ozone by 1 part
per billion by volume globally. By using epidemiologic ozone-
mortality relationships, this ozone reduction is estimated to pre-
vent30,000 premature all-cause mortalities globally in 2030, and
370,000 between 2010 and 2030. If only cardiovascular and
respiratory mortalities are considered, 17,000 global mortalities
can be avoided in 2030. The marginal cost-effectiveness of this 20%
methane reduction is estimated to be $420,000 per avoided
mortality. If avoided mortalities are valued at $1 million each, the
benefit is $240 per tonne of CH4 ($12 per tonne of CO2
equivalent), which exceeds the marginal cost of the methane
reduction. These estimated air pollution ancillary benefits of cli-
mate-motivated methane emission reductions are comparable
with those estimated previously for CO2. Methane mitigation
offers a unique opportunity to improve air quality globally and can
be a cost-effective component of international ozone manage-
ment, bringing multiple benefits for air quality, public health,
agriculture, climate, and energy.
human health  mortality  tropospheric ozone  air quality
Tropospheric ozone (O3) is an oxidant that damages agricul-ture, ecosystems, and materials. Ozone also adversely affects
human health and has been associated in epidemiologic studies
with daily premature mortality (1–10). Surface O3 concentra-
tions have historically increased in both polluted and remote
regions and now frequently exceed regulatory standards (11–14).
Global background surface O3 concentrations have roughly
doubled since preindustrial times (15), primarily because of
increases in anthropogenic emissions of nitrogen oxides (NOx)
and methane (CH4) (16), and are projected to continue to
increase (17, 18).
Tropospheric O3 is formed from photochemical reactions
involving NOx and volatile organic compounds (VOCs). Al-
though nonmethane VOCs are the dominant anthropogenic
VOCs contributing to O3 formation in polluted regions, CH4 is
the primary anthropogenic VOC in the global troposphere (19).
Because CH4 reacts slowly (lifetime of 8–9 yr), it affects global
background concentrations of O3. Because this background
underlies the O3 produced on urban and regional scales, CH4
mitigation reduces O3 concentrations by roughly the same
amount in polluted regions as in rural regions (19, 20).
Methane and O3 are also greenhouse gases, which rank behind
only carbon dioxide (CO2) in anthropogenic radiative forcing of
climate (21). Consequently, abatement of CH4 emissions both
reduces surface O3 concentrations everywhere and slows green-
house warming (19, 20). Methane abatement has been consid-
ered a low-cost means of addressing climate change (22, 23),
particularly to influence the short-term rate of climate change.
However, CH4 abatement has not been considered for air quality
management, mainly because O3 pollution has traditionally been
considered a local and regional problem, and the local benefits
of local CH4 reductions are small.
Here we examine the global reduction in O3 and consequent
decrease in premature human mortalities resulting from CH4
emission controls. We first estimate the global decrease in
surface O3 concentration due to CH4 mitigation, using the
MOZART-2 global three-dimensional tropospheric chemistry-
transport model (24, 25). This spatial distribution of O3 is then
overlaid on projections of population, and avoided premature
mortalities are estimated by using daily O3-mortality relation-
ships from epidemiologic studies (6–9). Results are presented as
the number of avoided premature mortalities due to the CH4
reduction, the marginal cost-effectiveness per avoided mortality
(using the marginal cost of CH4 mitigation), and the monetized
benefit per tonne of CH4 reduced [using a value of a statistical
life (VSL)].
Response of Global Surface Ozone to Methane Mitigation
Methods. We consider a CH4 emission reduction of 65 Mtyr1
(1 Mt  109 kg) (20% of current global anthropogenic
emissions), which is assumed to be immediate in 2010 and
sustained relative to the Intergovernmental Panel on Climate
Change Special Report on Emissions Scenarios (SRES) A2
scenario (26) until 2030. A compilation of global CH4 abatement
options in five industrial sectors (27) suggests that 65Mtyr1 can
be reduced by 2010 at a net cost savings, using identified
abatement options.
TheMOZART-2 simulations use uniform global mixing ratios
of CH4, and spatially and temporally distributed emissions of
other O3 precursors, as other studies have done (19, 28). We
conduct four simulations with MOZART-2, as shown in Table
1. Simulations I and III use CH4 mixing ratios and emissions of
other O3 precursors as specified for the Intergovernmental Panel
on Climate Change AR-4 2000 and 2030 A2 atmospheric
chemistry experiments (29). In the CH4 reduction cases (simu-
lations II and IV), the decreased CH4 mixing ratios are the
steady-state mixing ratios resulting from a 65 Mtyr1 emission
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reduction versus the corresponding base cases (simulations I and
III), assuming a CH4 feedback factor of 1.4 (28). We do not
consider any effects of changes in future climate on O3 distri-
butions in projecting to 2030 (30, 31), nor do we consider the
decrease in global mean temperature due to CH4 reductions,
which could amplify the O3 decrease that we estimate.
MOZART-2 has a horizontal resolution of 1.9° by 1.9° and 28
vertical levels. In all cases, we use meteorological fields from the
National Centers for Environmental Prediction reanalysis (32),
beginning in July 1998, with an 18-month initialization, before
focusing on results for the meteorological year 2000.
Results. Between 2000 and 2030 (simulations I and III), we
project the population-weighted global average 8-h daily maxi-
mum surface O3 mixing ratio to increase by 12.3 parts per billion
by volume (ppbv) (25%) (Table 2), primarily because of pro-
jected increases in anthropogenic emissions of NOx (70%) and
CH4 (48%). The 65 Mtyr1 CH4 emission reduction decreases
the steady-state population-weighted mean 8-h O3 by 1.16 ppbv
(1.9%, Table 2). This sensitivity is in agreement with other
models (18, 19, 28, 33), and these results together suggest that
global surface O3 responds fairly linearly to changes in CH4 (33).
Decreases in O3 due to CH4 reductions are widespread globally
(Fig. 1), with the largest O3 decreases occurring over the Middle
East, North Africa, and Europe, because of greater down-welling
from the free troposphere and greater availability of NOx. This
spatial pattern is similar to previous results (19, 20), suggesting
that the pattern is independent of the extent of methane
abatement. Methane controls initiated in 2010 will yield 81%
of this steady-state O3 change by 2030, assuming exponential
decay with a CH4 perturbation lifetime of 12 yr (28).
The steady-state change in O3 when 65 Mtyr1 are reduced
relative to the 2000 base case (simulation II vs. simulation I) is
virtually identical to the change in Table 2 (1.11 ppbv for
population-weighted 8-h O3), indicating that the projected
changes in nonmethane O3 precursors between 2000 and 2030
have little effect on the O3 sensitivity to CH4. This insensitivity
presumably reflects the fact that there is little change in hydroxyl
radical (OH) concentrations, because of similar emission ratios
of NOx to (CO  VOCs) in 2000 and 2030 (16). Therefore,
although the A2 scenario includes larger growth in emissions of
O3 precursors than other SRES scenarios, and larger than the
‘‘Current Legislation’’ scenario of Dentener et al. (18), this high
growth does not strongly affect the O3-CH4 sensitivity.
Indirect Effects of Methane Reductions on Particulate Matter (PM).
Methane reductions also indirectly affect PM concentrations
through complex oxidant chemistry. MOZART-2 (25) results
suggest that CH4 reductions cause a global net decrease in
inorganic PM, because of decreases in hydrogen peroxide that in
turn reduce sulfate production. Inorganic PM concentrations
also increase at some locations, where the increased gas-phase
oxidation (due to increased OH concentrations) dominates the
change in sulfate production. Although the global average
decrease is only0.5% of the inorganic PM (sulfate, nitrate, and
associated ammonium), the decrease is concentrated in popu-
lated regions. Confidence in the change in PM is lower than for
O3 because of competing influences on inorganic PM, and
because we have neglected changes in organic PM.
Global Mortality Benefits of Reduced Ozone
Methods. Ozone has been associated in epidemiologic studies
with adverse health effects including hospital admissions and
Table 2. Global average O3 mixing ratios (ppbv) in the 2000 and
2030 A2 base model runs (simulations I and III), and the
steady-state change in O3 due to a 65 Mtyr1 reduction in CH4
emissions, relative to the 2030 base (simulation IV minus
simulation III)
Parameter 2000 2030 A2 O3 2030
24-h average 29.1 33.6 0.82
8-h daily maximum 31.8 37.1 0.87
8-h maximum population-weighted 49.4 61.7 1.16







I: 2000 base case 1,760 124.8
II: 2000 CH4 reduction 1,460* 124.8
III: 2030 A2 2,163 212.7
IV: 2030 A2, CH4 reduction 1,865* 212.7
*Fixed global CH4 mixing ratios at steady state, corresponding to an emission
reduction of 65 Mtyr1 of CH4.
Fig. 1. Change in annual average daily maximum 8-h surface O3 mixing ratios, at steady state, due to a 65 Mtyr1 reduction in CH4 emissions relative to the
2030 A2 base case (simulation IV minus III).



























chronic respiratory conditions, and recent research provides
strong evidence for an association with daily premature mortal-
ity (1–10). We use the daily O3-mortality relationship ()
estimated by Bell et al. (6), using a distributed lag method for 95
cities in the United States, and apply this relationship globally.
Because long-term effects of O3 on mortality have not been
demonstrated (34), we do not consider possible chronic effects
of O3 or years of life lost due to premature mortality. Bell et al.
(6) directly use a large data set, and therefore their results are
not subject to publication bias, which can bias meta-analyses
high. The  estimated by Bell et al. (6) with a single-day lag is
much smaller than the  estimated in three recent meta-analyses
(7–9). However, the  of Bell et al. (6) with the distributed lag
method, used in this study, is much more comparable with the
meta-analyses (7–9), which are 22–36% higher. We consider the
sensitivity of our results to the uncertainties reported by Bell et
al. (6) and the meta-analyses (7–9). Although Bell et al. (6) focus
on the United States, similar results have been reported in North
America and Europe (5, 7–9). Few studies of O3 mortality have
been conducted elsewhere, although some such studies suggest
associations between O3 and mortality in other regions (35–37).
Although Bell et al. (6) find similar relationships between
ozone and mortality over all seasons in the United States, many
studies find reduced O3 impacts in winter, when O3 concentra-
tions are often lower (5, 8, 9). However, applying seasonal
differences in tropical regions is not straightforward. Available
studies also show adverse effects of O3 below current standards,
without identifying a clear threshold below which O3 does not
affect mortality (5, 6). Rather than imposing seasonally varying
relationships, we assume a low-concentration threshold of 25
ppbv, approximately the preindustrial mixing ratio (13, 15),
below which we neglect any effect of O3 on mortality. We apply
this threshold on each day, through all seasons, and consider the
sensitivity of our results to the threshold used.
We apply  to the total nonaccident baseline mortality rates,
using data for 14 world regions (38). Baseline mortality rates are
applied uniformly within each region, and are assumed to be
constant into the future. The spatial distribution of population
is modeled consistently with the SRES A2 scenario, growing to
9.17 billion in 2030 (26).
Avoided premature mortalities are estimated daily in each
model grid square, based on the maximum daily 8-h O3 mixing
ratio in the A2 base and CH4 control cases. The A2 base and CH4
control cases are constructed for the period 2000–2030 by
interpolating between simulations I, III, and IV. For the A2 base
case, 8-h O3 mixing ratios on each day and in each grid square
are interpolated between 2000 and 2030 (simulations I and III)
by using a constant percent growth rate. For the CH4 control
case, O3 decreases begin in 2010 and exponentially approach the
steady-state change (simulation IVminus III) with the 12-yr CH4
perturbation lifetime (see the supporting information, which is
published on the PNAS web site).
Results. Table 3 and Fig. 2 show that reducing CH4 emissions by 65
Mtyr1 in 2010 would prevent 30,000 all-cause premature mor-
talities in the year 2030 (0.04% of the total projectedmortalities),
with 370,000 avoided premature mortalities accumulated be-
tween 2010 and 2030. These avoided mortalities are distributed
globally, with the majority in highly populated regions (Table 3 and
Fig. 3). Mortality benefits per million people in 2030 are highest in
Africa, which has high baseline mortality rates, followed by Europe
and the eastern Mediterranean.
Table 4 shows a large sensitivity to  over the range of
uncertainties in Bell et al. (6) and three meta-analyses (7–9). The
avoidedmortalities also vary with the sensitivity of O3 to CH4 but
are rather insensitive to the low-concentration threshold over the
range considered. This insensitivity occurs because regions with
low O3 typically also have low population and small changes in
O3 due to CH4; O3 is below 25 ppbv on 12% of populated grid
square-days in 2030, but the number of avoided mortalities
decreases by only 2% relative to the no-threshold case.
The mortality benefits of O3 decreases are most uncertain in
developing nations, where fewer epidemiologic studies exist and
the general causes of death differ substantially from those in
industrialized nations. As a more conservative estimate, we
consider the avoided cardiovascular and respiratory (CR) mor-
talities, because these may be more closely linked to O3. We
apply the  for CRmortalities from Bell et al. (6), which is higher
than for total mortalities but not significantly different, to
baseline CR mortality rates. In Table 3, 17,000 premature CR
mortalities can be avoided globally in 2030 by the CH4 emission
reduction, with the greatest per capita benefits in Europe, where
relatively more people die of CR causes. Although our estimates
of avoided CR mortalities may be more robust in developing
nations than total mortalities, they likely miss important de-
creases in other causes of mortality. Henceforth, we use an
uncertainty range from the estimated avoided CR mortalities
(17,000 in 2030) to the highest number in Table 4 (56,000).
Effects of Changes in PM on Mortality. By using the changes in
inorganic PM in the previous section and a chronic PM-mortality
relationship (34), the avoided 2030 mortalities are estimated to
be less than, but comparable with, the O3 benefit (see the
Table 3. Avoided premature mortalities in 2030 by world region
and avoided mortalities per million people in 2030, resulting
from decreases in surface O3 due to a global CH4 emission











Africa 6,920 5.59 2,070 1.68
North America 1,110 2.81 700 1.77
Latin America 1,790 1.88 960 1.01
Southeast Asia 7,790 3.33 4,550 1.95
Western Europe 1,900 3.86 1,260 2.56
Eastern Europe and former
Soviet Union
1,790 3.50 1,560 3.06
Eastern Mediterranean 3,150 3.69 1,660 1.94
Western Pacific 500 2.86 310 1.77
East Asia 5,250 2.36 3,610 1.63
Global 30,200 3.29 16,700 1.82
Fig. 2. Avoided global premature mortalities from a 65 Mtyr1 CH4
emission reduction, beginning in 2010.
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supporting information). The effects of CH4 reductions on both
inorganic and organic PM should be further investigated, in-
cluding changes in PM precursor emissions from energy sources
possibly displaced because of increased CH4 availability.
Policy Analysis of Ozone Control by Means
of Methane Mitigation
A compilation of global CH4 abatement measures from five
industrial sectors (27) shows that41 Mtyr1 can be reduced at
a negative marginal cost (net cost-savings, through natural gas
recovery), which can be justified regardless of health benefits.
The 65Mtyr1 reduction has a marginal cost of$100 per tonne
of CH4 (2000 U.S. dollars), whereas the net cost of this reduction
is negative. We combine this marginal cost with the all-cause
avoided premature mortalities, which we convert to a constant
annualized benefit between 2010 and 2030 at a 5% yr1 discount
rate (see the supporting information), yielding $420,000 per
avoided mortality ($230,000–$760,000) as the marginal cost-
effectiveness of reducing 65 Mtyr1. The 65 Mtyr1 reduction
would be justified, in cost-benefit terms, for any globally aver-
aged VSL $420,000.
If we use $1 million as a reasonable globally averaged VSL
(39), the monetized benefit of reducing CH4 emissions is $240
per tonne of CH4 ($140–$450), or $12 per tonne of CO2
equivalent ($7–$22), which exceeds the marginal cost of the 65
Mtyr1 reduction ($100 per tonne of CH4). This estimate
neglects increases in the VSL as incomes grow, and only
considers 20 yr of benefits, whereas the O3 reductions will
continue growing beyond 2030 as population also grows. The
monetized benefit scales proportionally with the assumed
globally averaged VSL.
Because CH4 reductions have recently traded in international
markets at $10–$20 per tonne of CO2 equivalent, these results
suggest that current climate-motivated CH4 emission reductions
can roughly be justified by their benefits to air quality and health,
irrespective of other benefits of CH4 and O3 reductions. Further-
more, although the ancillary benefits of CO2 mitigation for air
quality and health have received attention (40), the ancillary
Fig. 3. Estimated avoided premature mortalities in 2030. (A) Total. (B) Per million people.
Table 4. Sensitivity of global 2030 avoided premature mortalities
to uncertain parameters
Parameter Base value Range
Avoided mortalities
over range
* 0.043 0.027–0.079 19,300–55,800




Using base values gives 30,200 avoided premature mortalities.
*Percent excess mortality per ppbv change in 8-h O3 mixing ratio. The range
spans the 95% confidence intervals of four studies (6–9).
†Range applied as scaling factors to the change in daily 8-h O3 in each grid
square.



























benefits of CH4 mitigation have not. Our estimate for CH4 of $12
per tonne ofCO2 equivalent is comparablewith the range estimated
previously for CO2 of $0.5–$140 per tonne of CO2 (41). Unlike the
ancillary benefits of CO2 mitigation, however, the ancillary benefits
of CH4 mitigation do not depend on the location or means of CH4
abatement, because the health benefits of CH4 mitigation result
from reactions involving the CH4 itself, and CH4 emissions affect
O3 globally regardless of emission location.
The compilation of CH4 abatement measures used in this
study (27) considers five industrial sectors (coal, oil, and natural
gas operations, landfills, and wastewater treatment) for which
methane abatement opportunities are well understood. Because
this compilation neglects abatement opportunities in the large
agricultural sector, it may underestimate the availability of
low-cost CH4 options, which would suggest that CH4 mitigation
is more cost-effective than estimated here. On the other hand,
a separate compilation by the U.S. Environmental Protection
Agency (42–44) suggests that less CH4 can be reduced at low cost
(see the supporting information and ref. 20).
Methane mitigation also benefits climate, because it reduces
the radiative forcing of both CH4 and O3. The 65 Mtyr1 CH4
reduction would decrease global radiative forcing by 0.14Wm2,
from CH4 and O3 together (at steady state). In contrast, reduc-
tions in NOx emissions decrease O3 forcing but increase CH4
forcing (45), with a net effect that could be positive or negative
depending on location (46).
Methane is also an important source of global energy, and
capturing half of the 65 Mtyr1 for energy use would provide
2% of current global natural gas production. The reductions
in O3 concentrations would also result in benefits to human
health (morbidity) and agriculture (47), which we previously
estimated to be smaller than the monetized benefits of avoided
mortalities estimated here (20). Methane mitigation may
further benefit air quality and climate by removing other
pollutants (e.g., VOCs) through the same actions that reduce
CH4 emissions, and by increasing the availability of natural gas,
which may reduce emissions of CO2 and air pollutants from the
combustion of other fossil fuels. In addition, because the
reductions in O3 are widespread globally, CH4 mitigation may
increase the net primary productivity of plants, causing in-
creased uptake of CO2 (48). Finally, methane mitigation may
affect stratospheric O3, but the direction of that inf luence is
not certain (49).
The effects of CH4 mitigation on surface O3 concentrations
are widespread globally, and are delayed. These characteristics
differ from other means of controlling O3, as well as most actions
to manage air quality, which abate local and regional pollution
over hours to weeks. Because of its global impacts, with small
local benefits, CH4 mitigation for air quality purposes (as for
climate) will best be implemented at national and international
levels. Furthermore, the potential for reducing O3 through CH4
mitigation is limited to a few parts per billion by volume.
Methane mitigation is therefore most appropriate for interna-
tional and long-term (decadal) O3 management, where CH4
mitigation for background O3 is complementary to local and
regional O3management through reductions in emissions of NOx
and nonmethane VOCs (20).
Important uncertainties in this study lie in the relationship
between O3 and mortality, and between CH4 emissions and
global surface O3 concentrations. Because CH4 affects O3 glo-
bally, this research highlights the need to improve understanding
of O3 mortality in developing nations, and of the relationship
between O3 and mortality at low concentration, including con-
sideration of possible thresholds. Future research should also
investigate the effects of CH4 mitigation on PM concentrations,
and its implications for air quality, public health, and climate.
Finally, future research should further examine opportunities to
abate CH4 emissions, emphasizing the large agricultural sector.
Conclusions
As background O3 concentrations increase, meeting national O3
standards increasingly becomes an international problem (50–
52). Methane mitigation reduces surface O3 everywhere, offer-
ing a unique opportunity to improve air quality globally. We
estimate that reducing 20% of current global anthropogenic
CH4 emissions, which can be achieved at a net cost-savings by
using identified technologies, will reduce O3 mixing ratios glo-
bally by 1 ppbv and prevent 30,000 premature mortalities
globally in 2030 and 370,000 mortalities between 2010 and
2030. If these mortalities are valued at $1 million each, the
monetized benefit is$240 per tonne of CH4, or$12 per tonne
of CO2 equivalent. These benefits exceed the marginal costs of
the 20% anthropogenic CH4 reduction ($100 per tonne of
CH4) and demonstrate that CH4 mitigation has ancillary benefits
to air quality and human health that are comparable with those
previously estimated for CO2. Methane mitigation benefits air
quality, public health, agriculture, climate, and energy, and
should increasingly be considered a cost-effective component of
international long-term O3 management.
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